Renal Involvement in Down Syndrome: Developmental and Clinical Perspectives
Diagnostics · 03.11.2026 · 16 (21) · 3630
DOI: 10.3390/diagnostics16213630 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 03.11.2026. Verfasst von Bojana Andrejić Višnjić und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina.
Abstract (Originalsprache)
With the increasing life expectancy of individuals with Down syndrome (DS), kidney disease has emerged as an important yet under-recognized contributor to long-term morbidity and mortality in this population. This narrative review summarizes current knowledge regarding the developmental, structural, histopathological, and clinical aspects of renal involvement in DS. A literature search was conducted, and studies addressing renal structure, function, development, or pathology in individuals with DS (clinical studies, autopsy studies, case reports, and experimental studies) were included. Available evidence indicates that renal involvement in DS extends beyond congenital anomalies to include altered nephrogenesis, acquired glomerulopathies, and progressive functional impairment. Histopathological studies of fetal kidneys suggest altered nephrogenesis and delayed renal maturation in DS, potentially resulting in reduced nephron endowment. However, the long-term functional consequences of these developmental findings remain uncertain. Reported acquired glomerular diseases are heterogeneous and include IgA nephropathy, focal segmental glomerulosclerosis, membranous nephropathy, ANCA-associated glomerulonephritis, and several rarer entities. Conventional renal biomarkers may underestimate kidney dysfunction in DS because of altered body composition and reduced muscle mass, while evidence regarding novel biomarkers such as NGAL and KIM-1 remains limited. Renal involvement in DS is multifactorial and likely reflects the interplay between disturbed nephrogenesis, developmental renal abnormalities, and acquired renal disease, resulting in increased renal vulnerability throughout life. Improved awareness, earlier nephrological surveillance, and validation of sensitive renal biomarkers may facilitate earlier detection of kidney injuries and improve long-term renal outcomes in individuals with DS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.
- Institute for Child and Youth Health Care of Vojvodina, 21000 Novi Sad, Serbia.
- Center for Pathology and Histology, University Clinical Center of Vojvodina, 21000 Novi Sad, Serbia.
ORCID-Profile: Bojana Andrejić Višnjić, Vesna Stojanović, Milena Šunjević, Milana Bosanac
Förderung
- Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina
Zitieren
APA
Andrejić Višnjić, B., Samardžić Lukić, M., Stojanović, V., Trivunić Dajko, S., Šunjević, M., Kovač, N., & Bosanac, M. (2026). Renal Involvement in Down Syndrome: Developmental and Clinical Perspectives. Diagnostics, 16(21), 3630. https://doi.org/10.3390/diagnostics16213630
Vancouver
Andrejić Višnjić B, Samardžić Lukić M, Stojanović V, Trivunić Dajko S, Šunjević M, Kovač N, et al. Renal Involvement in Down Syndrome: Developmental and Clinical Perspectives. Diagnostics. 2026;16(21):3630. doi:10.3390/diagnostics16213630
BibTeX
@article{AndrejiVinji2026,
author = {Andrejić Višnjić, Bojana and Samardžić Lukić, Maja and Stojanović, Vesna and Trivunić Dajko, Sandra and Šunjević, Milena and Kovač, Nataša and Bosanac, Milana},
title = {Renal Involvement in Down Syndrome: Developmental and Clinical Perspectives},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {21},
pages = {3630},
doi = {10.3390/diagnostics16213630}
}
EUVIMED